safety of semaglutide The Injections for Diabetes Efficacy and safety of semaglutide

10.1186/S12933-015-0193-4/TABLES/7 32 MyatA.RedwoodS

Weight loss continues at approximately 1.5-2% per week during this phase

The 8 to 12 week window often marks a shift into more consistent weekly weight loss, with patients averaging 1 to 2 pounds per week as appetite suppression deepens and behavioral changes solidify

While gastrointestinal side effects are the most commonly reported adverse events, long-term studies affirm its overall safety and tolerability

Invariably, this limits the availability of the drug for those that need it most, mainly diabetic patients with elevated blood sugar levels

Continuous Care : Monthly interactions for dosage optimization and consistent support